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Background
Studies evidences that high proviral loads (PVL) are
crucial for the leukemogenesis in the development of
ATLL. PVL seems to be stable for years in each indivi-
dual, but varies substantially among subjects. Previous
reports suggest that co-infection of HTLV-1 carriers
with S. stercoralis may shorten ATLL onset, thus gen-
erating a hypothetical “intermediate state”.W e
explored this hypothesis by comparing the PVL of
ATLL patients and HTLV-1/Strongyloides co-infected
individuals.
Methods
We determined PVL in three groups: (1) HTLV-1
asymptomatic carriers without a history of Strongyloi-
diasis [AC] (n=8); (2) virus carriers with previous epi-
sodes of Strongyloidiasis [SS] (n=8); and (3) patients
with ATLL [AT] (n=8). History of Strongyloidiasis was
defined by the patient’s report and a positive result with
a ELISA. Peripheral blood mononuclear cells (PBMC)
were isolated to measure PVL by Sybr-Green quantita-
tive PCR. PVL was expressed as HTLV-1 tax copy num-
ber/10
4 PBMC. Non-parametric tests were used for the
statistical analysis.
Results
The PVL in AT was significantly higher than that in AC
[7375±4492SD vs.1698±106SD][p=0.01]. PVL was also
higher in SS than in AC [4746±1712SD vs.1698±106SD]
[p=0.002]. Interestingly, no differences were found
between AT and SS [7375±4492SD vs.4746± 1712SD]
[p=0.16].
Conclusion
Our results support the hypothesis that HTLV-1/S. ster-
coralis co-infected subjects are at higher risk of develop-
ing ATLL as they seem to share with ATLL patients
impaired immunological mechanisms to control virus
propagation. Further studies are needed to fully charac-
terize the co-infected condition.
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